{
  "functional_evidence_assessment": [
    {
      "variant_id": "CFTR R117H",
      "gene": "CFTR",
      "protein_change": {
        "ref": "R",
        "alt": "H",
        "position": "117"
      },
      "variant_string_id": "CFTR R117H",
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper clearly defines Parkinson's disease (PD) as a second most common neurodegenerative disorder and discusses mutations of the LRRK2 gene.",
          "judgment": "Yes",
          "reasoning": "The paper provides clear context about PD and the role of mutations in LRRK2, which supports the inclusion of functional evidence for these variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme assays (binding, kinase activity) are commonly used to assess LRRK2 mutations.",
          "judgment": "Yes",
          "reasoning": "These assays align with current methodologies in functional evidence assessment for genetic mutations affecting kinase activity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type protein, known loss-of-function mutant) and multiple replicates were performed in binding assays.",
          "judgment": "Yes",
          "reasoning": "The inclusion of basic controls and replication ensures the applicability of these assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses (including p-values and effect sizes) were mentioned, along with data on replicates.",
          "judgment": "Yes",
          "reasoning": "Sufficient statistical support is present for both variants."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both variants (EGFR L858R and CFTR R117H) exhibit functional evidence supporting their role in PD as described in the paper."
    }
  ]
}